Validation of impacts on brain activity, by taking a single dose of test food - Validation of impacts on brain activity, by taking a single dose of test food

CPCC Company Limited0 sites24 target enrollmentSeptember 1, 2023

ConditionsHealthy male/female adults

Overview

Phase: 未知
Intervention: Not specified
Conditions: Healthy male/female adults
Sponsor: CPCC Company Limited
Enrollment: 24
Status: Completed
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

September 1, 2023

End Date

October 12, 2022

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Investigators

Sponsor

CPCC Company Limited

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

•(1\) Subjects being under some kind of continuous medical treatment, including the test period. (2\) Subjects who have periodically used health\-specific / functional / health foods including supplements, which might affect the autonomic nervous system, metabolism and sleep. (3\) Subjects with incompatible chest (e.g., thick bodyhair, pacemaker\-fitting) for heartbeat measurements. (4\) Subjects with excessive alcohol intake (not less than 60 g/day/week). (5\) Subjects with extremely irregular eating habits, and subjects having an irregular life rhythm with irregular shift work or midnight one. (6\) At the moment of informed consent, subjects who are under the other clinical tests with some kind of medicine/food, or participated in those within four weeks after the current trial, or are planning to join those after the consent. (7\) Subjects who are under a large stress condition with some kind of life event, such as house\-moving, transfer, bereavement, etc., within three months before the agreement for this trial and during the test period. (8\) Subjects with any difficulty in giving up drinking since the day before the scheduled date of this trial. (9\) Subjects with previous and/or current medical history of serious diseases in heart, liver, kidney and/or digestive organs. (10\) Subjects getting excessive exercise every day. (11\) Subjects with a serious symptom of premenstrual syndrome. (12\) Subjects who have been determined as poor blood circulation, according to the doctor's oral questions at the moment of informed consent. (13\) Subjects planning to vaccinate within three days before this study. (14\) Pregnant, possibly pregnant, and lactating women. (15\) Subjects having some kind of drug and/or food allergy. (16\) Subjects who break out in a rash from putting electrodes on the head and chest. (17\) Others who have been determined as ineligible for participation, judging from the principal/sub investigator's opinions.